CDK4 Inhibitors Thwart Immunity by Inhibiting Phospho-RB-NF-κB Complexes.
PD-L1 plays a central role in immune recognition of cancer cells. In this issue of Molecular Cell, Jin et al. (2019) report that a phosphorylated retinoblastoma protein contacts the DNA-binding domain of p65 NF-κB, thereby blocking transcription of PD-L1.